SIRT3 and metabolic dysfunction-associated steatotic liver disease: We have reported that SIRT3 overexpression increases hepatic levels of MTP, increases mitochondrial FAO, and rescues NAFLD in MTP heterozygous mice fed a high-fat diet for 16 weeks [130].